Sphingosine kinase and sphingosine 1-phosphate in the heart: A decade of progress

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 203-212

  Karliner, Joel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioprotection; FTY720; Ischemia reperfusion injury; S1P lyase; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

FINGOLIMOD; HIGH DENSITY LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; ISCHEMIC PRECONDITIONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ALDEHYDE-LYASES; ANIMALS; CARDIOTONIC AGENTS; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MYOCARDIUM; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE;

MUS;

EID: 84868551757     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.06.006     Document Type: Article

References (157)

1. O. Cuvillier, G. Pirianov, B. Keluser, P.G. Vanek, A. Coso, S. Gutkind, and S.S. Spiegel Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate Nature 381 1996 800 803
2. T. Imamura, J. Ohgane, S. Ito, T. Ogawa, N. Hattori, S. Tanaka, and K. Shiota CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons Genomics 76 2001 117 125
3. T. Okada, G. Ding, H. Sonoda, T. Kajimoto, Y. Hga, A. Khosrowbeygi, S. Gao, N. Miwa, S. Jahangeer, and S. Nakamura Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis J. Biol. Chem. 280 2005 36318 36325
4. H. Liu, M. Sugiura, V.E. Nava, L.C. Edsal, K. Kono, S. Poulton, S. Milstien, T. Kohama, and S. Spiegel Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform J. Biol. Chem. 275 2000 19513 19520
5. R. Alemany, C.J. van Koppen, K. Dannebeg, M. ter Braak, and D. Meyer zu Heringdorf Regulation and functional roles of sphingosine kinases Naunyn Schmiedebergs Arch. Pharmacol. 374 2007 413 428
6. K. Mizugishi, T. Yamashita, A. Olivera, G.F. Miller, S. Spiegel, and R.L. Proia Essential role for sphingosine kinases in neural and vascular development Mol. Cell. Biol. 25 2005 11113 11121
7. M.L. Allende, T. Sasaaki, H. Kawai, A. Olivera, Y. Mi, G. Echten-Deckert, R. Hajdu, M. Dosenbach, C.A. Keohane, S. Mandala, S. Spiegel, and R.L. Proia Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 J. Biol. Chem. 279 2004 52487 52492
8. J. Michaud, M. Kohno, R.L. Proia, and T. Hla Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice FEBS Lett. 580 2006 4607 4612
9. L. Cavallini, R. Venerando, G. Miotto, and A. Alexandre Ganglioside GM1 protection from apoptosis of rat heart fibroblasts Arch. Biochem. Biophys. 370 1999 156 162
10. S.M. Pitson, P.A. Moretti, J.R. Zebol, H.E. Lynn, P. Xia, M.A. Vadas, and B.W. Wattenberg Activation of sphingosine kinase 1 by ERK 1/2-mediated phosphorylation EMBO J. 22 2003 5491 5500
11. P. Xia, L. Wang, P.A. Moretti, N. Albanese, F. Chai, S.M. Pitson, R.J. D'Andreaa, J.R. Gamble, and M.A. Vadas Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor alpha signaling J. Biol. Chem. 277 2002 7996 8003
12. T. Fujita, T. Okada, S. Hayashi, S. Hahangeer, N. Miwa, and S. Nakamura Delta-catenin/NRRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1 Biochem. J. 382 2004 717 723
13. M. Maceyka, S.G. Payne, S. Milstien, and S. Spiegel Aminocyclase 1 is a sphingosine kinase 1-interacting protein FEBS Lett. 568 2004 30 34
14. T.M. Leclercq, P.A. Moretti, M.A. Vadas, and S.M. Pitson Eukaryotic elongation factor 1 interacts with sphingosine kinase and directly enhances its catalytic activity J. Biol. Chem. 283 2008 9606 9614
15. E. Lacana, M. Maceyka, S. Milstien, and S. Spiegel Cloning and characterization of a protein kinase A anchoring protein (AKAP)-related protein that interacts with and regulates sphingosine kinase 1 activity J. Biol. Chem. 277 2002 32947 32953
16. D. Kovanich, M.A. van der Heyden, T.T. Aye, T.A. Van Veen, A.J. Heck, and A. Scholten Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type 1 cAMP-dependent protein kinase ChemBioChem 11 2010 963 971
17. Y. Fukuda, Y. Aoyama, A. Wada, and Y. Igarashi Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonist-induced phosphorylation Biochim. Biophys. Acta 1636 2004 12 21
18. J. Sun, G. Yan, A. Ren, B. You, and J.K. Liao FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1 Circ. Res. 99 2006 468 476
19. H. Hayashi, H. Hankagami, Y. Takami, H. Kolriyama, M. Mori, K. Tamai, J. Sun, K. Nagao, M. Morishita, and Y. Kaneda FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1 Arterioscler. Thromb. Vasc. Biol. 29 2009 909 914
20. S. Hayashi, T. Okada, N. Igararshi, T. Fujita, S. Jahngeer, and S. Nakamura Identification and characterization of RPK118, a novel sphingosine kinase-1-binding protein J. Biol. Chem. 277 2002 33319 33324
21. 2 + signals triggered by different phospholipid pathways in antigen stimulation of human mast cells J. Biol. Chem. 277 2002 17255 17262
22. D. Meyer zu Heringdorf Lysophospholipid receptor-dependent and -independent calcium signaling J. Cell. Biochem. 92 2004 937 948
23. K. Venkataraman, S. Thangada, J. Michaud, M.L. Oo, Y. Ai, Y.M. Lee, M. Wu, N.S. Parikh, F. Khan, R.L. Proia, and T. Hla Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient Biochem. J. 397 2006 461 471
24. N. Ancellin, C. Colmont, J. Su, Q. Li, N. Mittereder, S.S. Chae, S. Stefansson, G. Liau, and T. Hla Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation J. Biol. Chem. 277 2002 6667 6675
25. D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.-H. Suguelas, N. Leducq, I. Seif, A. Parini, and O. Cuvillier Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis Circ. Res. 100 2007 41 49
26. V. Anelli, C.R. Gault, A.B. Cheng, and L.M. Obeid Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2 J. Biol. Chem. 283 2008 3365 3375
27. D.A. Vessey, M. Kelley, J. Zhang, L. Li, R. Tao, and J.S. Karliner Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart J. Biochem. Mol. Toxicol. 21 2007 273 279
28. T.A. Taha, K. Kitatani, M. El-Alwani, J. Bielawski, Y.A. Hannun, and L.M. Obeid Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis FASEB J. 20 2006 482 484
29. R. Tao, J. Zhang, D.A. Vessey, N. Honbo, and J.S. Karliner Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes Cardiovasc. Res. 74 2007 56 63
30. M. Maceyka, H. Sankkala, N.C. Hait, H. Le Stunff, H. Liu, R. Toman, C. Collier, M. Zhang, L.S. Satin, A.H. Merrill Jr., S. Milstien, and S. Spiegel SphK1 and Sphk2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J. Biol. Chem. 280 2005 37118 37129
31. D. Pelletier, and D.A. Hafler Fingolimod for multiple sclerosis N. Engl. J. Med. 366 2012 339 347
32. D.A. Vessey, L. Li, Z.-Q. Jin, M. Kelley, N. Honbo, J. Zhang, and J.S. Karliner A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning Oxid. Med. Cell. Longev. 2011 2011 961059 (Epub 2011 Apr 18)
33. D.A. Vessey, L. Li, I. Imhof, N. Honbo, J.S. Karliner. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic preconditioning, submitted for publication.
34. L. Gomez, M. Paillard, M. Price, Q. Chen, G. Teixeira, S. Spiegel, and E.J. Lesnefsky A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection Basic Res. Cardiol. 106 2011 1341 1353
35. G.M. Strub, M. Paillard, J. Liang, L. Gomez, J.C. Allegood, N.C. Hait, M. Maceyka, M.M. Price, Q. Chen, D.C. Simpson, T. Kordula, S. Milstien, E.J. Lesnefsky, and S. Spiegel Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration FASEB J. 25 2011 600 612
36. N.C. Hait, J. Allegood, M. Maceyka, G.M. Strub, K.B. Harikumar, S.K. Singh, C. Luo, R. Marmorstein, T. Kordula, S. Milstien, and S. Spiegel Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate Science 325 2009 1254 1257
37. S.M. Pitson Regulation of sphingosine kinase and sphingolipid signaling Trends Biochem. Sci. 36 2011 97 107
38. B.W. Wattenberg Role of sphingosine kinase localization in sphingolipid signaling World J. Biol. Chem. 26 2010 362 368
39. S.M. Pitson, P.A. Morretti, J.R. Zebol, H.E. Lynn, P. Xia, M.A. Vadas, and B.W. Wattenberg Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation EMBO J. 22 2003 5491 5500
40. J.A. Hengst, J.M. Guilford, T.E. Fox, X. Wang, E.J. Conroy, and J.K. Yun Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition Arch. Biochem. Biophys. 492 2009 62 73
41. K.E. Jarman, P.A. Moretti, J.R. Zebol, and S.M. Pitson Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium-and integrin-binding protein 1 J. Biol. Chem. 285 2010 483 492
42. V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol. Ther. 115 2007 84 105
43. M. Maceyka, S.G. Payne, S. Milstien, and S. Spiegel Sphingosine kinase, sphingosine-1-phosphate, and apoptosis Biochim. Biophys. Acta 1585 2002 193 201
44. J.D. Saba, and T. Hla Point-counterpoint of sphingosine 1-phosphate metabolism Circ. Res. 94 2004 724 734
45. 1 receptor-mediated ERK signaling and desensitization J. Cardiovasc. Pharmacol. 53 2009 486 494
46. R. Pappu, S.R. Schwab, I. Cornelissen, J.P. Pereira, J.B. Regard, Y. Xu, E. Camerer, Y.-W. Zheng, Y. Huang, J.G. Cyster, and S.R. Coughlin Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 2007 295 298
47. N. Murata, K. Sato, J. Kon, H. Tomura, M. Yanagita, A. Kuwabara, M. Ul, and F. Okajima Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions Biochem. J. 352 2000 809 815
48. F. Okajma Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim. Biophys. Acta 1582 2002 132 137
49. D.H. Deutschman, J.S. Carstens, R.L. Klepper, W.S. Smith, M.T. Page, T.R. Young, L.A. Gleason, N. Nakajima, and R.A. Sabbadini Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate Am. Heart J. 146 2003 62 68
50. M. Tani, T. Sano, M. Ito, and Y. Igarashi Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets J. Lipid Res. 46 2005 2458 2467
51. K. Venkataraman, Y.M. Lee, J. Michaud, S. Thangada, Y. Ai, H.L. Bonkovsky, N.S. Parikh, C. Habrukowich, and T. Hla Vascular endothelium as a contributor of plasma sphingosine 1-phosphate Circ. Res. 102 2008 669 676
52. S.R. Schwab, J.P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J.G. Cyster Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients Science 309 2005 1735 1739
53. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate J. Physiol. 489 1995 701 707
54. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat. Rev. Mol. Cell Biol. 4 2003 397 407
55. T. Hla, M.J. Lee, N. Ancellin, J.H. Paik, and M.J. Kluk Lysophospholipid-receptor revelations Science 294 2001 1875 1878
56. J. Chun, E.J. Goetzl, T. Hla, Y. Igarashi, K.R. Lynch, W. Moolenaar, S. Pyne, and G. Tigyi International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature Pharmacol. Rev. 54 2002 265 269
57. S. Pyne, and N.J. Pyne Sphingosine 1-phosphate signalling in mammalian cells Biochem. J. 349 2000 385 402
58. N. Nakajima, A.L. Cavalli, D. Biral, C.C. Glembotski, P.M. McDonough, P.D. Ho, R. Betto, D. Sandora, P.T. Palade, C.A. Dettbarn, R.E. Klepper, and R.A. Sabbadini Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate Eur. J. Biochem. 267 2000 5679 5686
59. D. Mazurais, P. Robert, B. Gout, I. Berrebi-Bertrand, M.P. Laville, and T. Calmels Cell type-specific localization of human cardiac S1P receptors J. Histochem. Cytochem. 50 2002 661 670
60. G.C. Zondag, F.R. Postma, I.V. Etten, I. Verlaan, and W.H. Moolenaar Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1 Biochem. J. 330 1998 605 609
61. 2 + mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition J. Biol. Chem. 273 1998 27104 27110
62. J. Kon, K. Sato, T. Watanabe, H. Tomura, A. Kuwabara, T. Kimura, K. Tamama, T. Ishizuka, N. Murata, T. Kanda, I. Kobayashi, H. Ohta, M. Ui, and F. Okajima Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells J. Biol. Chem. 274 1999 23940 23947
63. J.R. Nofer, M. Van der Giet, M. Tolle, I. Wolinska, K. von Wnuck Lipinski, H.A. Baba, U.J. Tietge, A. Dodecke, I. Ishii, B. Kleuser, M. Schafers, M. Fobker, W. Zidek, G. Assmann, J. Chun, and B. Levkau HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J. Clin. Invest. 113 2004 569 581
64. 2 sphingosine 1-phosphate receptor knockout mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 2007 R440 R446
65. C.H. Liu, S. Thangada, M.J. Lee, J.R. Van Brocklyn, S. Spiegel, and T. Hla Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1 Mol. Biol. Cell 10 1999 1179 1190
66. J. Igarashi, and T. Michel Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae J. Biol. Chem. 275 2000 32363 32370
67. T. Kohno, A. Wasa, and Y. Igarashi N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization FASEB J. 16 2002 983 992
68. P.J. Gonzalez-Cabrera, T. Hla, and H. Rosen Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics J. Biol. Chem. 282 2007 7254 7264
69. J.S. Karliner Mechanisms of cardioprotection by lysophospholipids J. Cell. Biochem. 92 2004 1095 1103
70. N. Nakajima, A.L. Cavalli, D. Biral, C.C. Glembotski, P.M. McDonough, P.D. Ho, R. Eto, D. Sanona, P.T. Palade, C.A. Dettbard, R.E. Klepper, and R.A. Sabbadini Expression and characterization of Edg-1 receptors in rat cardiomyocytes. Calcium deregulation in response to sphingosine 1-phosphate Eur. J. Biochem. 267 2000 5679 5686
71. P. Robert, P. Tsui, M.P. Laville, G.P. Livi, J.H.M. Sarau, A. Bril, and I. Berrebi-Bertrand EDG1 receptor stimulation leads to cardiac hypertophy in rat neonatal myocytes J. Mol. Cell. Cardiol. 33 2001 1589 1606
72. 2 Cardiovasc. Res. 58 2003 170 177
73. M.G. Sanna, J. Liao, E. Jo, C. Alfonso, M.-Y. Ahn, M.S. Peterson, B. Webb, S. Lefebvre, J. Chun, N. Gray, and H. Rosen Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J. Biol. Chem. 279 2004 13839 13848
74. L.K. Landeen, D.A. Dederko, C.S. Kondo, B.S. Hu, N. Aroonsakool, J.H. Haga, and W.R. Giles Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes Am. J. Physiol. Heart Circ. Physiol. 294 2008 H736 H749
75. Y.T. Tsukada, M.G. Sanna, H. Rosen, and R.A. Gottlieb S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias J. Cardiovasc. Pharmacol. 50 2007 660 669
76. S. Pan, Y. Mi, C. Pally, C. Beerli, A. Chen, D. Guerini, K. Hinterding, B. Nuesslein-Hildesheim, T. Tuntland, S. Lefebvre, Y. Liu, W. Gao, A. Chu, V. Brinkmann, C. Bruns, M. Streiff, C. Cannet, N. Cooke, and N. Gray A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model Chem. Biol. 13 2006 1227 1234
77. O. Oyama, N. Sugimoto, X. Qi, N. Takuwa, K. Mizugishi, J. Koizumi, and Y. Takuwa The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice Cardiovasc. Res. 78 2008 301 307
78. C. Donati, and P. Bruni Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response Biochim. Biophys. Acta 1758 2006 2037 2048
79. C.C. Wendler, and S.A. Rivkees Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development Dev. Biol. 291 2006 264 277
80. R.R. Poulsen, C.M. McClaskey, S.A. Rivkees, and C.C. Wendler The sphingosine-1-phosphate receptor 1 mediates S1P action during cardiac development BMC Dev. Biol. 11 2011 37
81. A. Pebay, C.S. Bonder, and S.M. Pitson Stem cell regulation by lysophospholipids Prostaglandins Other Lipid Mediat. 84 2007 83 97
82. Z. Zhao, Z. Chen, X. Zhao, F. Pan, M. Cai, T. Wang, H. Zhang, J.R. Lu, and M. Lei Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions J. Biomed. Sci. 18 2011 37
83. K.J. Sattler, S. Elbasan, P. Keul, M. Elter-Schulz, C. Bode, M.H. Graler, M. Brocker-Preuss, T. Budde, R. Erbel, G. Heusch, and B. Levkau Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease Basic Res. Cardiol. 105 2010 821 832
84. M. Knapp, M. Baranowski, D. Czarnoswski, A. Lisowska, P. Zabieiski, J. Gorski, and W. Musial Plasma sphingosine-1-phosphate concentration is educed in patients with myocardial infarction Med. Sci. Monit. 15 2009 CR490 CR493
85. D.A. Vessey, M. Kelley, l. Li, Y. Huang, H.-Z. Zhou, B.-Q. Zhu, and J.S. Karliner Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury Med. Sci. Monit. 12 2006 318 324
86. K.M. Argraves, A.A. Sethi, P.J. Gazzolo, B.A. Wilerson, A.T. Remaley, A. Tybjaerg-Hansen, G.B. Nordestgaard, S.D. Yeatts, K.S. Nicholas, J.L. Barth, and W.S. Argraves S1P, dihydro-S1P and c24:1 ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease Lipids Health Dis. 10 2011 70
87. J.S. Karliner, N. Honbo, K. Summers, M.O. Gray, and E.J. Goetzl The lysophospholipids sphingosine-1-posphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes J. Mol. Cell. Cardiol. 33 2001 1713 1717
88. J. Zhang, N. Honbo, E.J. Goetzl, K. Chatterjee, J.S. Karliner, and M.O. Gray Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia Am. J. Physiol. Heart Circ. Physiol. 293 2007 H3150 H3158
89. M.D. Davis, J.J. Clemens, T.L. Macdonald, and K.R. Lynch Sphingosine 1-phosphate analogs as receptor antagonists J. Biol. Chem. 280 2005 9833 9841
90. i-mediated cAMP and contractile responses J. Biol. Chem. 283 2008 11954 11963
91. 3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2944 H2951
92. M.L. Allende, and R.L. Proia Sphingosine-1-phosphate receptors and the development of the vascular system Biochim. Biophys. Acta 1582 2002 222 227
93. M.L. Allende, T. Yamashita, and R.L. Proia G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation Blood 102 2003 3665 3667
94. M.L. Allende, D. Zhou, D.N. Kalkofen, S. Benhamed, G. Tuymetoa, C. Borowski, A. Bendelac, and R.L. Proia S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues FASEB J. 22 2008 307 315
95. Y.-M. Lee, K. Venkatgaraman, S.-I. Hwang, D.K. Han, and T. Hla A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC) Prostaglandins Other Lipid Mediat. 84 2007 154 162
96. I.N. Mungrue, P. Zhao, Y. Yao, H. Meng, C. Rau, J.V. Havel, T.G. Gorgels, A.A. Bergen, W.R. MacLellan, T.A. Drake, K.I. Costrom, and A.J. Lusis ABcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model Arterioscler. Thromb. Vasc. Biol. 31 2011 2806 2812
97. T.F. Solbach, B. Paulus, M. Weyand, T. Eschenhagen, O. Zolk, and M.F. Fromm ATP-binding cassette transporters in human heart failure Naunyn Schmiedebergs Arch. Pharmacol. 377 2008 231 243
98. Y. Hisano, N. Kobayashi, A. Kawahara, A. Yamaguchi, and T. Nishi The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720 J. Biol. Chem. 286 2011 1758 1766
99. Z.-Q. Jin, H.-Z. Zhou, P. Zhu, N. Honbo, D. Mochly-Rosen, R.O. Messing, E.J. Goetzl, J.S. Karliner, and M.O. Gray Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1970 H1977
100. S. Lecour, R.M. Smith, B. Woodward, L.H. Opie, L. Rochette, and M.N. Sack Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection J. Mol. Cell. Cardiol. 34 2002 509 518
101. Z.-Q. Jin, E.J. Goetzl, and J.S. Karliner Sphingosine kinase activation mediates ischemic preconditioning in murine heart Circulation 110 2004 1980 1989
102. F. Tonelli, K.G. Lim, C. Loveridge, J. Long, S.M. Pitson, G. Tigyi, R. Bittman, S. Pyne, and N.J. Pyne FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells Cell. Signal. 22 2010 1536 1542
103. Z.-Q. Jin, and J.S. Karliner Low dose N,N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCε dependent mechanism Cardiovasc. Res. 71 2006 725 734
104. 2 + channel conductance Circ. Res. 75 1994 981 989
105. E. Suzuki, K. Handa, M.S. Toledo, and S. Hakomori Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert Proc. Natl. Acad. Sci. U. S. A. 101 2004 14788 14793
106. D.A. Vessey, L. Li, M. Kelley, J. Zhang, and J.S. Karliner Sphingosine can pre-and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate J. Biochem. Mol.Toxicol. 22 2008 113 118
107. D.A. Vessey, M. Kelley, and J.S. Karliner A rapid radioassay for sphingosine kinase Anal. Biochem. 337 2005 136 142
108. A. Billich, F. Bornancin, P. Dévay, D. Mechtcheriakova, N. Urtz, and T. Baumruker Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases J. Biol. Chem. 278 2003 47408 47415
109. K.G. Lim, F. Tonelli, Z. Li, X. Lu, R. Bittman, S. Pyne, and N.J. Pyne FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells J. Biol. Chem. 286 2011 18633 18640
110. C.C. Yeh, D. Malhotra, M.C. Huang, B.-Q. Zhu, E.J. Goetzl, D.A. Vessey, J.S. Karliner, and M.J. Mann Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1193 H1199
111. Z.-Q. Jin, J. Zhang, Y. Huang, H.E. Hoover, D.A. Vessey, and J.S. Karliner A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury Cardiovasc. Res. 76 2007 41 50
112. H.-F. Duan, H. Wang, J. Yi, H.-J. Liu, Q.-W. Zhang, L.-G. Li, T. Zhang, Y. Lu, C.-T. Wu, and L.-S. Wang Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its post-ischemic failure Hum. Gene Ther. 18 2007 1119 1128
113. M. Kim, M. Kim, N. Kim, V.D. D'Agati, C.W. Emala Sr., and H.T. Lee Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways Am. J. Physiol. Renal Physiol. 293 2007 F1827 F1835
114. Z.Q. Zhao, J.S. Corvera, M.E. Jalos, F. Kerendi, N.P. Wang, R.A. Guyton, and J. Vinten-Johansen Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am. J. Physiol. Heart Circ. Physiol. 285 2003 H579 H588
115. H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T.T. Cung, E. Bonnefoy, D. Angoulvant, J.F. Aupetit, G. Finet, X. Andre-Gouet, J.C. Macia, F. Raczka, R. Rossi, R. Itti, G. Kirkorian, G. Derumeaux, and M. Ovize Long-term benefit of postconditioning Circulation 117 2008 1037 1044
116. Z.-Q. Jin, J.S. Karliner, and D.A. Vessey Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation Cardiovasc. Res. 79 2008 134 140
117. D.A. Vessey, L. Li, M. Kelley, and J.S. Karliner Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia Biochem. Biophys. Res. Commun. 375 2008 425 429
118. P. Bandhuvula, N. Honbo, G.Y. Wang, Z.Q. Jin, H. Fyrst, M. Zhang, A.D. Borowsky, L. Dillard, J.S. Karliner, and J.D. Saba S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart Am. J. Physiol. Heart Circ. Physiol. 300 2011 H1753 H1761
119. T. Fujita, K. Inoue, S. Yamamoto, T. Ikumoto, S. Sasaki, R. Toyama, K. Chiba, Y. Hoshino, and T. Okumoto Fungal metabolites: part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite J. Antibiot. (Tokyo) 47 1994 208 215
120. S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.J. Shei, D. Card, C. Keohane, M. Rosenbach, J. Hale, C.L. Lynch, K. Rupprecht, W. Parsons, and H. Rosen Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
121. T. Hla, and V. Brinkmann Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation Neurology 76 8 Suppl. 3 2011 S3 S8
122. V. Brinkmann, S. Chen, L. Feng, D. Pinschewer, Z. Nikolova, and R. Hof FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression Transplant. Proc. 33 2001 530 531
123. V. Brinkmann, D. Pinschewer, K. Chiba, and L. Feng FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation Trends Pharmacol. Sci. 21 2000 49 52
124. E.E. Egom, Y. Ke, H. Musa, T.M. Mohamed, T. Wang, E. Cartwright, R.J. Solaro, and M. Lei FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/AKT signaling J. Mol. Cell. Cardiol. 48 2010 406 414
125. E.E. Egom, T.M. Mohamed, M.A. Mamas, Y. Shi, W. Liu, D. Chirico, S.E. Stringer, Y. Ke, M. Shaheen, T. Wang, S. Chacko, X. Wang, R.J. Solaro, F. Fath-Ordoubadi, E.J. Cartwright, and M. Lei Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1487 H1495
126. W. Liu, M. Zi, R. Naumann, S. Ulm, J. Jin, D.M. Taglieri, S. Prehar, J. Gui, H. Tsui, R.P. Xiao, L. Neyses, R.J. Solaro, Y. Ke, E.J. Cartwright, E.M. Lei, and X. Wang Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart Circulation 124 2011 2702 2715
127. U. Hofmann, N. Burkard, C. Vogt, A. Thoma, S. Frantz, G. Ertl, O. Ritter, and A. Bonz Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia/reperfusion Cardiovasc. Res. 83 2009 285 293
128. U. Hofmann, K. Hu, F. Walter, N. Burkard, G. Ertl, J. Bauersachs, O. Ritter, S. Frantz, and A. Bonz Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia/reperfusion Br. J. Pharmacol. 160 2010 1243 1251
129. G. Wang, R.Y. Kim, I. Imhof, N. Honbo, K. Li, N. Kumar, F.S. Luk, B-Q Zhu, J.S. Karliner, R.L. Raffai. Immunosuppression by oral FTY720 is cardioprotective and extends longevity in a mouse model of severe coronary atherosclerosis, submitted for publication.
130. F. Mullershausen, F. Zecri, C. Cetin, A. Billich, D. Guerini, and K. Seuwen Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors Nat. Chem. Biol. 5 2009 428 434
131. D. Hausenloy, and D. Yellon New directions for protecting the heart against ischemia/reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway Cardiovasc. Res. 61 2004 448 460
132. L. Lacerda, S. Somers, L.H. Opie, and S. Lecour Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway Cardiovasc. Res. 84 2009 201 208
133. S.J. Somers, M. Frias, L. Lacerda, L.H. Opie, and S. Lecour Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection Cardiovasc. Drugs Ther. 26 2012 227 237
134. J.M. Kovarik, G.J. Riviere, D. Neddermann, S. Maton, T.L. Hunt, and R.L. Schmouder A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod J. Clin. Pharmacol. 48 2008 303 310
135. FDA Drug Safety Communication: revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolomid) http://www.fda.gov/Drugs/DrugSafety/ucm303192.htm Issued 05-14-2012
136. R. Kacimi, D.A. Vessey, N. Honbo, and J.S. Karliner Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response J. Mol. Cell. Cardiol. 43 2007 85 91
137. N. Gellings Lowe, J.S. Swaney, K.M. Moreno, and R.A. Sabbadini Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts Cardiovasc. Res. 82 2009 303 312
138. D. Pchejetski, C. Foussai, C. Alfarano, O. Lairez, D. Caliise, C. Guilbeaau-Frugier, S. Schaak, M.H. Seguelas, E. Wanecq, P. Valet, A. Parini, and O. Kunduzova Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1 Eur. Heart J. Oct 25 2011 [Epub ahead of print]
139. J.-R. Nofer, B. Levkau, I. Wolinska, R. Junder, M. Fobker, A. von Ecardstein, U. Seedorf, and G. Assmann Suppression of endothelial ell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids J. Biol. Chem. 276 2001 34480 34485
140. T. Kimura, K. Sato, E. Malchinkhuu, T. Tomura, K. Tamma, A. Kuabara, M. Murakami, and F. Okajima High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors Arterioscler. Thromb. Vasc. Biol. 23 2003 1283 1288
141. M. Tolle, B. Levkau, B. Kleuser, and M. van der Giet Sphingosine-1- phosphate and FTY720 as anti-atherosclerotic lipid compounds Eur. J. Clin. Invest. 37 2007 171 179
142. J.-R. Nofer, M. Bot, M. Brodde, P.J. Taylor, P. Salm, V. Brinkmann, T. van Berkel, G. Assmann, and E.A. Biessen FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 115 2007 501 508
143. P. Keul, M. Tolle, S. Lucke, K. von Wnuck Lipinski, G. Heusch, M. Schuchardt, M. van der Giet, and B. Levkau The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 607 613
144. J. Igarashi, M. Miyoshi, T. Hashimoto, Y. Kubota, and H. Kosak Statins
145. P. Keul, K. Sattler, and B. Levkau HDL and its sphingosine-1-phosphate content in cardioprotection Heart Fail. Rev. 12 2007 301 306
146. K.M. Argraves, and W.S. Argraves HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects J. Lipid Res. 48 2007 2325 2333
147. R. Tao, H.E. Hoover, N. Honbo, M. Kalinowski, C.C. Alano, J.S. Karliner, and R. Raffai High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate Am. J. Physiol. Heart Circ. Physiol. 298 2010 1022 1028
148. M.A. Frias, U. Lang, C. Gerber-Wicht, and R.W. James Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis Cardiovasc. Res. 85 2010 118 126
149. B. Levkau, S. Hermann, G. Theilmeier, M. van der Diet, J. Chun, O. Schober, and M. Schafers High-density lipoprotein stimulates myocardial perfusion in vivo Circulation 110 2004 3355 3359
150. 3 lysophospholipid receptor Circulation 114 2006 1403 1409
151. C. Christoffersen, H. Obinata, S.B. Kumaraswamy, S. Galvani, J. Ahnström, M. Sevvana, C. Egerer-Sieber, Y.A. Muller, T. Hla, L.B. Nielsen, and B. Dahlbäck Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M Proc. Natl. Acad. Sci. U. S. A. 108 2011 9613 9618
152. P. Keul, M. Tölle, S. Lucke, K. von Wnuck Lipinski, G. Heusch, M. Schuchardt, M. van der Giet, and B. Levkau The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 607 613
153. J.-R. Nofer, M. Bot, M. Brodde, P.J. Taylor, P. Salm, V. Brinkmann, G. Assmann, and E.A. Biessen FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 115 2007 501 508
154. T. Blom, N. Bäck, A.L. Mutka, R. Bittman, Z. Li, A. de Lera, P.T. Kovanen, U. Diczfalusy, and E. Ikonen FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages Circ. Res. 106 2010 720 729
155. R. Klingenberg, J.-R. Nofer, M. Rudling, F. Bea, E. Blessing, M. Preusch, H.J. Grone, H.A. Katus, G.K. Hansson, and T.J. Dengler Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 2392 2399
156. P. Keul, S. Lucke, K. von Wnuck Lipinski, C. Bode, M. Gräler, G. Heusch, and B. Levkau Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis Circ. Res. 108 2011 314 323
157. S. Zhang, M.H. Picard, E. Vasile, Y. Zhu, R.L. Raffai, K.H. Weisgraber, and M. Krieger Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice Circulation 111 2005 3457 3464